Albeit GBM is known to promote the exhaustion of T cells, the failure of immune checkpoint inhibitors (ICI) treatment suggests that this CD8+ T cell subset is mainly senescent rather than exhausted. This evidence concerns the gene CD8A and glioblastoma.